Moderna says Health Canada has approved its mRNA vaccine, shown in a handout photo, to protect against respiratory syncytial virus in adults age 60 and older. THE CANADIAN PRESS/HO-Moderna **MANDATORY CREDIT**
In a news release, Moderna said it expects the RSV vaccine — called mRESVIA — to be available in early 2025. Earlier this year, the National Advisory Committee on Immunization recommended RSV immunization for adults 75 years and older. According to the Public Health Agency of Canada's wastewater surveillance, the level of RSV circulating is currently"moderate" across much of the country.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
Fonte: SooToday - 🏆 8. / 85 Consulte Mais informação »
Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
Fonte: BurnabyNOW_News - 🏆 14. / 77 Consulte Mais informação »
Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
Fonte: PGCitizen - 🏆 65. / 51 Consulte Mais informação »
Health Canada approves Moderna’s mRNA RSV vaccine, company saysHealth Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older.
Fonte: CHEK_News - 🏆 59. / 55 Consulte Mais informação »
Health Canada approves Moderna's mRNA RSV vaccine, company saysHealth Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older, available next year.
Fonte: CTVNews - 🏆 1. / 99 Consulte Mais informação »
Health Canada approves Moderna’s mRNA RSV vaccine, company saysAgency approves the vaccine to protect against respiratory syncytial virus in adults age 60 and older
Fonte: globeandmail - 🏆 5. / 92 Consulte Mais informação »